Dalian BIO-CHEM Company Limited

SHSE:603360 Stock Report

Market Cap: CN¥5.0b

Dalian BIO-CHEM Future Growth

Future criteria checks 1/6

Dalian BIO-CHEM is forecast to grow earnings and revenue by 14.4% and 13.7% per annum respectively. EPS is expected to grow by 13.2% per annum. Return on equity is forecast to be 18.1% in 3 years.

Key information

14.4%

Earnings growth rate

13.2%

EPS growth rate

Chemicals earnings growth34.7%
Revenue growth rate13.7%
Future return on equity18.1%
Analyst coverage

Low

Last updated18 Mar 2024

Recent future growth updates

No updates

Recent updates

Dalian BIO-CHEM Company Limited (SHSE:603360) Surges 41% Yet Its Low P/E Is No Reason For Excitement

Apr 01
Dalian BIO-CHEM Company Limited (SHSE:603360) Surges 41% Yet Its Low P/E Is No Reason For Excitement

Here's Why Dalian BIO-CHEM (SHSE:603360) Can Manage Its Debt Responsibly

Mar 08
Here's Why Dalian BIO-CHEM (SHSE:603360) Can Manage Its Debt Responsibly

Earnings and Revenue Growth Forecasts

SHSE:603360 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20251,508486N/A4421
12/31/20241,291424N/A3811
9/30/20231,104349372433N/A
3/31/20231,220377421478N/A
12/31/20221,257403346480N/A
9/30/20221,318426243400N/A
6/30/20221,19235541240N/A
3/31/20221,08229720211N/A
12/31/20211,006250-50142N/A
9/30/2021875203-69144N/A
6/30/202182721713207N/A
3/31/2021768184-11178N/A
12/31/2020750222101211N/A
9/30/2020837251195268N/A
6/30/2020920322201254N/A
3/31/2020934365243293N/A
12/31/2019872307177240N/A
9/30/201972727171155N/A
6/30/201962619547145N/A
3/31/201953915039136N/A
12/31/201852814547135N/A
9/30/201851712760130N/A
6/30/20184711094693N/A
3/31/20184401004879N/A
12/31/20174101005676N/A
9/30/2017392107104115N/A
6/30/2017393109N/A132N/A
3/31/2017402107N/A125N/A
12/31/201638998N/A120N/A
9/30/201636582N/A99N/A
12/31/201532857N/A74N/A
12/31/201434764N/A60N/A
12/31/201329149N/A54N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 603360's forecast earnings growth (14.4% per year) is above the savings rate (2.9%).

Earnings vs Market: 603360's earnings (14.4% per year) are forecast to grow slower than the CN market (25.5% per year).

High Growth Earnings: 603360's earnings are forecast to grow, but not significantly.

Revenue vs Market: 603360's revenue (13.7% per year) is forecast to grow slower than the CN market (14.9% per year).

High Growth Revenue: 603360's revenue (13.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 603360's Return on Equity is forecast to be low in 3 years time (18.1%).

Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.